Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 1, 2016, Pages 132-138.e4

  Kim, Donghee ^a,b   Chung, Goh Eun ^a   Kwak, Min Sun ^a   Seo, Hyo Bin ^a   Kang, Jin Hwa ^a   Kim, Won ^c   Kim, Yoon Jun ^d   Yoon, Jung Hwan ^d   Lee, Hyo suk ^d   Kim, Chung Yong ^d  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

BMI; Marker; NASH; Prognosis; Steatosis

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; POPULATION RESEARCH; REMISSION; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING HABIT; WAIST CIRCUMFERENCE; ABDOMEN; ABDOMINAL RADIOGRAPHY; AGED; ANTHROPOMETRY; BLOOD ANALYSIS; DIAGNOSTIC IMAGING; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; QUESTIONNAIRE; RISK ASSESSMENT; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BLOOD CHEMICAL ANALYSIS; BODY FAT DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RADIOGRAPHY, ABDOMINAL; RISK ASSESSMENT; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84958973737     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.07.024     Document Type: Article

References (37)

1. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142:1592-1609.
2. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
3. Kim D., Kim W.R., Kim H.J., et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013, 57:1357-1365.
4. Ahima R.S., Osei S.Y. Adipokines in obesity. Front Horm Res 2008, 36:182-197.
5. Choi S.Y., Kim D., Oh B.H., et al. General and abdominal obesity and abdominal visceral fat accumulation associated with coronary artery calcification in Korean men. Atherosclerosis 2010, 213:273-278.
6. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
7. Fox C.S., Massaro J.M., Hoffmann U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
8. Eguchi Y., Eguchi T., Mizuta T., et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 2006, 41:462-469.
9. Holt H.B., Wild S.H., Wood P.J., et al. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 2006, 49:141-148.
10. Thomas E.L., Hamilton G., Patel N., et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005, 54:122-127.
11. Park B.J., Kim Y.J., Kim D.H., et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008, 23:900-907.
12. van der Poorten D., Milner K.L., Hui J., et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008, 48:449-457.
13. Yim J.Y., Kim D., Lim S.H., et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care 2010, 33:2665-2670.
14. Kwak M.S., Kim D., Chung G.E., et al. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int 2015, 35:944-952.
15. Kim D., Choi S.Y., Park E.H., et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012, 56:605-613.
16. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
17. Day C.P. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 2006, 6:19-25.
18. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
19. Chung S.J., Kim D., Park M.J., et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008, 57:1360-1365.
20. Meng K., Lee C.H., Saremi F. Metabolic syndrome and ectopic fat deposition: what can CT and MR provide?. Acad Radiol 2010, 17:1302-1312.
21. Larter C.Z., Chitturi S., Heydet D., et al. A fresh look at NASH pathogenesis: part 1-the metabolic movers. J Gastroenterol Hepatol 2010, 25:672-690.
22. Snijder M.B., Visser M., Dekker J.M., et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat: the Health ABC Study. Diabetologia 2005, 48:301-308.
23. Porter S.A., Massaro J.M., Hoffmann U., et al. Abdominal subcutaneous adipose tissue: a protective fat depot?. Diabetes Care 2009, 32:1068-1075.
24. Thorne A., Lonnqvist F., Apelman J., et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002, 26:193-199.
25. Klein S., Fontana L., Young V.L., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004, 350:2549-2557.
26. Kim J.Y., van de Wall E., Laplante M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637.
27. Larter C.Z., Yeh M.M., Van Rooyen D.M., et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol 2009, 24:1658-1668.
28. Heilbronn L., Smith S.R., Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 2004, 28(Suppl 4):S12-S21.
29. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. Consultation WHOE.
30. Hernaez R., Lazo M., Bonekamp S., et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011, 54:1082-1090.
31. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
32. Machado M.V., Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease: a critical appraisal. J Hepatol 2013, 58:1007-1019.
33. Patel N.S., Doycheva I., Peterson M.R., et al. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2015, 13:561-568 e1.
34. Permutt Z., Le T.A., Peterson M.R., et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease: MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012, 36:22-29.
35. Noureddin M., Lam J., Peterson M.R., et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013, 58:1930-1940.
36. Lin S.C., Heba E., Wolfson T., et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol 2015, 13:1337-1345 e6.
37. van der Poorten D., Samer C.F., Ramezani-Moghadam M., et al. Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?. Hepatology 2013, 57:2180-2188.